Evozyne
PrivateLast Round
Series B
Sep 27, 2023
Total Funding Raised
$144.38M
Company Overview
Evozyne is a biotechnology company that operates a data-driven molecular engineering platform to develop innovative proteins with enhanced functionalities tailored to meet specific health challenges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Carbon Capture
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evozyne Comps
Public and private peers based on sector, stage, and business model.
Evozyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 27, 2023 | ||||
| Series A | Apr 1, 2021 | ||||
| Seed | Apr 27, 2020 |
Key People
Founding team and executive leadership
Evozyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fidelity Management & Research Company | Series A, Series B |
| OrbiMed | Series B |
| Paragon Biosciences | Seed, Series B, Series A |
| NVentures | Series B |
| Valor Equity Partners | Series B, Series A |
Evozyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evozyne's valuation, stock price, and market status.
